HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesLisofylline
Chemical structure of CAS 100324-81-0

Lisofylline

In Stock•Starting at $183 for 2 mg•Purity ≥ 98%
CAS No.100324-81-0
MDL No.MFCD00867573
MFC13H20N4O3
MW280.32
InChI KeyNSMXQKNUPPXBRG-SECBINFHSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
2 mg98%$183In Stock
5 mg98%$326In Stock
10 mg98%$574In Stock
25 mg98%$1144In Stock
50 mg98%$1905In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

(R)-Lisofylline is a synthetic small molecule with the structure 1-(5-hydroxyhexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione, featuring (R)-configuration. It was under development for type 1 diabetes mellitus treatment and acts as an anti-inflammatory and immunomodulator. It is the enantiomer of (S)-lisofylline.

CAS No.100324-81-0
Product NameLisofylline

Associated Conditions

type 1 diabetes mellitus
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.

Diabetologia • Vol. 45, Issue 9 • 2002
PMID: 12242464DOI: 10.1007/s00125-002-0901-y

Developmental differences in the role of interleukins in hyperoxic lung injury in animal models.

Frontiers in bioscience : a journal and virtual library • Vol. 7 • 2002
PMID: 12108429DOI: 10.2741/A866

Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome.

Critical care medicine • Vol. 30, Issue 1 • 2002
PMID: 11902249DOI: 10.1097/00003246-200201000-00001

Lisofylline: anti-acute respiratory distress syndrome or just anti-inflammatory?

Critical care medicine • Vol. 30, Issue 1 • 2002
PMID: 11902272DOI: 10.1097/00003246-200201000-00037

Documentation

Similar Products